Gv 2019 Gp, L.l.c. - Net Worth and Insider Trading

Gv 2019 Gp, L.l.c. Net Worth

The estimated net worth of Gv 2019 Gp, L.l.c. is at least $84 Million dollars as of 2024-05-20. Gv 2019 Gp, L.l.c. is the 10% Owner of Prime Medicine Inc and owns about 11,862,498 shares of Prime Medicine Inc (PRME) stock worth over $84 Million. Details can be seen in Gv 2019 Gp, L.l.c.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gv 2019 Gp, L.l.c. has not made any transactions after 2023-06-21 and currently still holds the listed stock(s).

Transaction Summary of Gv 2019 Gp, L.l.c.

Gv 2019 Gp, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gv 2019 Gp, L.l.c. owns 4 companies in total, including Decibel Therapeutics Inc (DBTX) , IonQ Inc (IONQ) , and Verve Therapeutics Inc (VERV) among others .

Click here to see the complete history of Gv 2019 Gp, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Gv 2019 Gp, L.l.c.

Ticker	Comapny	Transaction Date	Type of Owner
DBTX	Decibel Therapeutics Inc	2021-02-11	10 percent owner
IONQ	IonQ Inc	2021-09-30	10 percent owner
VERV	Verve Therapeutics Inc	2021-06-16	10 percent owner
		2023-06-21	10 percent owner

Gv 2019 Gp, L.l.c. Latest Holdings Summary

Gv 2019 Gp, L.l.c. currently owns a total of 1 stock. Gv 2019 Gp, L.l.c. owns 11,862,498 shares of Prime Medicine Inc (PRME) as of June 21, 2023, with a value of $84 Million.

Latest Holdings of Gv 2019 Gp, L.l.c.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PRME	Prime Medicine Inc	2023-06-21	11,862,498	7.08	83,986,486

Holding Weightings of Gv 2019 Gp, L.l.c.

Gv 2019 Gp, L.l.c. Form 4 Trading Tracker

According to the SEC Form 4 filings, Gv 2019 Gp, L.l.c. has made a total of 16 transactions in Prime Medicine Inc (PRME) over the past 5 years, including 1 buys and 15 sells. The most-recent trade in Prime Medicine Inc is the sale of 56,408 shares on June 21, 2023, which brought Gv 2019 Gp, L.l.c. around $847,812.

Insider Trading History of Gv 2019 Gp, L.l.c.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gv 2019 Gp, L.l.c. Trading Performance

GuruFocus tracks the stock performance after each of Gv 2019 Gp, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gv 2019 Gp, L.l.c. is 10.92%. GuruFocus also compares Gv 2019 Gp, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Gv 2019 Gp, L.l.c. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gv 2019 Gp, L.l.c.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gv 2019 Gp, L.l.c.

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	29.54
Relative Return to S&P 500(%)	23.49

Gv 2019 Gp, L.l.c. Ownership Network

Ownership Network List of Gv 2019 Gp, L.l.c.

No Data

Ownership Network Relation of Gv 2019 Gp, L.l.c.

Gv 2019 Gp, L.l.c. Owned Company Details

What does Decibel Therapeutics Inc do?

Who are the key executives at Decibel Therapeutics Inc?

Gv 2019 Gp, L.l.c. is the 10 percent owner of Decibel Therapeutics Inc. Other key executives at Decibel Therapeutics Inc include See Remarks James B Murphy , See Remarks Anna Trask , and director & See Remarks Laurence Reid .

Decibel Therapeutics Inc (DBTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Decibel Therapeutics Inc (DBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Decibel Therapeutics Inc (DBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Decibel Therapeutics Inc (DBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Decibel Therapeutics Inc Insider Transactions

No Available Data

What does IonQ Inc do?

Who are the key executives at IonQ Inc?

Gv 2019 Gp, L.l.c. is the 10 percent owner of IonQ Inc. Other key executives at IonQ Inc include Chief Revenue Officer Rima Alameddine , director & President and CEO Peter Hume Chapman , and director & Chief Strategy Officer Jungsang Kim .

IonQ Inc (IONQ) Insider Trades Summary

Over the past 18 months, Gv 2019 Gp, L.l.c. made no insider transaction in IonQ Inc (IONQ). Other recent insider transactions involving IonQ Inc (IONQ) include a net sale of 104,634 shares made by Peter Hume Chapman , a net sale of 55,864 shares made by Thomas G. Kramer , and a net sale of 42,076 shares made by Jungsang Kim .

In summary, during the past 3 months, insiders sold 86,556 shares of IonQ Inc (IONQ) in total and bought 115,000 shares, with a net purchase of 28,444 shares. During the past 18 months, 720,604 shares of IonQ Inc (IONQ) were sold and 115,000 shares were bought by its insiders, resulting in a net sale of 605,604 shares.

IonQ Inc (IONQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

IonQ Inc Insider Transactions

No Available Data

What does Verve Therapeutics Inc do?

Who are the key executives at Verve Therapeutics Inc?

Gv 2019 Gp, L.l.c. is the 10 percent owner of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include See Remarks Andrew D. Ashe , Chief Administrative Officer Joan Nickerson , and director & 10 percent owner Krishna Yeshwant .

Verve Therapeutics Inc (VERV) Insider Trades Summary

Over the past 18 months, Gv 2019 Gp, L.l.c. made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 1,108 shares made by Allison Dorval , a net purchase of 1,800,000 shares made by Krishna Yeshwant , and a net purchase of 76,000 shares made by Andrew D. Ashe .

In summary, during the past 3 months, insiders sold 1,514 shares of Verve Therapeutics Inc (VERV) in total and bought 76,000 shares, with a net purchase of 74,486 shares. During the past 18 months, 3,487 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,872,513 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verve Therapeutics Inc Insider Transactions

No Available Data

What does Prime Medicine Inc do?

Who are the key executives at Prime Medicine Inc?

Gv 2019 Gp, L.l.c. is the 10 percent owner of Prime Medicine Inc. Other key executives at Prime Medicine Inc include director & 10 percent owner Robert Nelsen , 10 percent owner Arch Venture Partners X, Llc , and 10 percent owner Alphabet Inc. .

Prime Medicine Inc (PRME) Insider Trades Summary

Over the past 18 months, Gv 2019 Gp, L.l.c. made 15 insider transaction in Prime Medicine Inc (PRME) with a net sale of 1,422,190. Other recent insider transactions involving Prime Medicine Inc (PRME) include a net purchase of 3,200,000 shares made by Arch Venture Partners X, Llc , a net purchase of 3,200,000 shares made by Arch Venture Partners Xii, Llc , and a net purchase of 3,200,000 shares made by Robert Nelsen .

In summary, during the past 3 months, insiders sold 0 shares of Prime Medicine Inc (PRME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,422,190 shares of Prime Medicine Inc (PRME) were sold and 9,600,000 shares were bought by its insiders, resulting in a net purchase of 8,177,810 shares.

Prime Medicine Inc (PRME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Prime Medicine Inc Insider Transactions

No Available Data

Gv 2019 Gp, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Gv 2019 Gp, L.l.c.. You might contact Gv 2019 Gp, L.l.c. via mailing address: 1600 Amphitheatre Pkwy, Mountain View Ca 94043.

Discussions on Gv 2019 Gp, L.l.c.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.